- Home
- AXP vs MRK Comparison
AXP vs MRK Comparison
Compare AXP & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXP
- MRK
- Stock Information
- Founded
- AXP 1850
- MRK 2000
- Country
- AXP United States
- MRK United States
- Employees
- AXP N/A
- MRK N/A
- Industry
- AXP Finance: Consumer Services
- MRK Biotechnology: Pharmaceutical Preparations
- Sector
- AXP Finance
- MRK Health Care
- Exchange
- AXP Nasdaq
- MRK Nasdaq
- Market Cap
- AXP 227.7B
- MRK 218.8B
- IPO Year
- AXP N/A
- MRK N/A
- Fundamental
- Price
- AXP $361.67
- MRK $88.00
- Analyst Decision
- AXP Buy
- MRK Buy
- Analyst Count
- AXP 21
- MRK 15
- Target Price
- AXP $327.57
- MRK $105.14
- AVG Volume (30 Days)
- AXP 2.6M
- MRK 12.1M
- Earning Date
- AXP 10-17-2025
- MRK 10-30-2025
- Dividend Yield
- AXP 0.92%
- MRK 3.70%
- EPS Growth
- AXP 9.59
- MRK 20.41
- EPS
- AXP 14.88
- MRK 6.49
- Revenue
- AXP $65,294,000,000.00
- MRK $63,616,000,000.00
- Revenue This Year
- AXP $19.50
- MRK $1.76
- Revenue Next Year
- AXP $8.57
- MRK $5.11
- P/E Ratio
- AXP $24.04
- MRK $13.49
- Revenue Growth
- AXP 10.22
- MRK 1.82
- 52 Week Low
- AXP $220.43
- MRK $73.31
- 52 Week High
- AXP $362.32
- MRK $106.62
- Technical
- Relative Strength Index (RSI)
- AXP 68.90
- MRK 60.08
- Support Level
- AXP $349.18
- MRK $86.91
- Resistance Level
- AXP $357.73
- MRK $88.79
- Average True Range (ATR)
- AXP 8.19
- MRK 1.50
- MACD
- AXP 2.87
- MRK 0.14
- Stochastic Oscillator
- AXP 97.47
- MRK 85.96
About AXP American Express Company
American Express is a global financial institution, operating in about 130 countries, that provides consumers and businesses charge and credit card payment products. The company also operates a highly profitable merchant payment network. The firm operates in four segments: US consumer services, US commercial services, international card services, and global merchant and network services. In addition to payment products, the company's commercial business offers expense management tools, consulting services, and business loans.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).